Product NDC: | 21695-474 |
Proprietary Name: | Lansoprazole |
Non Proprietary Name: | lansoprazole |
Active Ingredient(s): | 15 mg/1 & nbsp; lansoprazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-474 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020406 |
Marketing Category: | NDA |
Start Marketing Date: | 20091111 |
Package NDC: | 21695-474-30 |
Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (21695-474-30) |
NDC Code | 21695-474-30 |
Proprietary Name | Lansoprazole |
Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (21695-474-30) |
Product NDC | 21695-474 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lansoprazole |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20091111 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | LANSOPRAZOLE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |